Tourmaline Bio Cash Flow Statement 2019-2024 | TRML

Fifteen years of historical annual cash flow statements for Tourmaline Bio (TRML).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20232022202120202019
$-42.12$-19.70$-47.83$-22.71$-18.16
$-0.49$0.01$1.05$0.54$0.38
$14.70$12.34$4.48$1.34$0.20
$14.21$12.34$5.53$1.88$0.58
$0$0$0$0$0
$0$0$0$0$0
$-0.04$0.19$1.32$0.10$0.32
$-2.45$-0.05$-1.34$0.56$-1.48
$-0.17$0.90$2.32$1.61$-0.09
$-28.08$-6.46$-39.99$-19.21$-17.66
$-0.06$-0.07$-2.44$-1.29$-0.56
$0$0$0$0$0
$0$-5.00$0$0$0
$0$0$0$0$0
$3.90$0$-93.95$-132.01$0
$3.90$0$-93.95$-132.01$0
$0$0$0$0$0
$3.84$-5.07$-96.39$-133.30$-0.56
$0$-0.15$0$0$0
$0$0$0$0$0
$0$-0.15$0$0$0
$0.14$0$140$1.65$0.00
$91.97$20.00$140$132$37.50
$0$0$0$0$0
$64.75$0$-2.65$-0.53$-1.30
$157$19.85$137$131$36.20
$132$8.32$1.03$-21.39$17.98
$5.77$0.20$3.78$1.02$0.23
$0$0$0$0$0